Header Logo

Connection

DONALD MAHONEY, JR. to Female

Back to Details
This is a "connection" page, showing publications DONALD MAHONEY, JR. has written about Female.
DONALD MAHONEY, JR.
Connection Strength
0.161
Female
  1. Anemia in at-risk populations--what should be our focus? Am J Clin Nutr. 2008 Dec; 88(6):1457-8.
    View in: PubMed
    Score: 0.012
  2. Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):214-21.
    View in: PubMed
    Score: 0.012
  3. Increased pulmonary artery pressures among adolescents with sickle cell disease. J Pediatr Hematol Oncol. 2005 Dec; 27(12):654-8.
    View in: PubMed
    Score: 0.010
  4. Infantile cytomegalovirus-associated autoimmune hemolytic anemia. J Pediatr Hematol Oncol. 2001 Jun-Jul; 23(5):318-20.
    View in: PubMed
    Score: 0.007
  5. Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study. Neuro Oncol. 2000 10; 2(4):213-20.
    View in: PubMed
    Score: 0.007
  6. Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol. 2000 Mar; 18(6):1285-94.
    View in: PubMed
    Score: 0.007
  7. Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol. 2000 Feb; 18(4):813-23.
    View in: PubMed
    Score: 0.007
  8. Barriers to and Facilitators of Iron Therapy in Children with Iron Deficiency?Anemia. J Pediatr. 2020 04; 219:202-208.
    View in: PubMed
    Score: 0.007
  9. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study. J Clin Oncol. 1998 May; 16(5):1712-22.
    View in: PubMed
    Score: 0.006
  10. Role of staging bone marrow examination in children with Hodgkin disease. Med Pediatr Oncol. 1998 Mar; 30(3):175-7.
    View in: PubMed
    Score: 0.006
  11. Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial. J Clin Oncol. 1998 Jan; 16(1):246-54.
    View in: PubMed
    Score: 0.006
  12. Mixed neuronal-glial tumors (gangliogliomas) in children. Pediatr Neurosurg. 1996 Jun; 24(6):306-13.
    View in: PubMed
    Score: 0.005
  13. High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study. J Clin Oncol. 1996 Feb; 14(2):382-8.
    View in: PubMed
    Score: 0.005
  14. The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet. 2015 Nov; 47(11):1326-1333.
    View in: PubMed
    Score: 0.005
  15. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study. Cancer. 1995 May 15; 75(10):2623-31.
    View in: PubMed
    Score: 0.005
  16. Study of the molecular defects in pyruvate kinase deficient patients affected by nonspherocytic hemolytic anemia. Blood Cells Mol Dis. 1995; 21(1):49-55.
    View in: PubMed
    Score: 0.005
  17. Radiological case of the month. Thymic cyst with secondary abscess formation. Arch Pediatr Adolesc Med. 1994 Nov; 148(11):1187-8.
    View in: PubMed
    Score: 0.005
  18. Chronic neutropenia of childhood: frequent association with parvovirus infection and correlations with bone marrow culture studies. Br J Haematol. 1993 Sep; 85(1):57-62.
    View in: PubMed
    Score: 0.004
  19. An analysis of outcomes and treatment costs for children undergoing splenectomy for chronic immune thrombocytopenia purpura. J Pediatr Surg. 2012 Aug; 47(8):1537-41.
    View in: PubMed
    Score: 0.004
  20. Functional deficiency of protein C associated with mesenteric venous thrombosis and splenic infarction. Am J Pediatr Hematol Oncol. 1991; 13(2):168-71.
    View in: PubMed
    Score: 0.004
  21. Assessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemia. Magn Reson Imaging. 2010 Apr; 28(3):363-71.
    View in: PubMed
    Score: 0.003
  22. Acquired von Willebrand syndrome and Wilms tumor: not always benign. Pediatr Blood Cancer. 2009 Mar; 52(3):392-4.
    View in: PubMed
    Score: 0.003
  23. Acquired immune deficiency, myelodysplasia, and acute nonlymphocytic leukemia associated with monosomy 7 and t(3;3) (q21;q26) in a child with Langerhans cell histiocytosis. Am J Pediatr Hematol Oncol. 1989; 11(2):153-7.
    View in: PubMed
    Score: 0.003
  24. Lack of effect of lithium carbonate in patients with glycogenosis Ib. Am J Dis Child. 1987 Sep; 141(9):985-6.
    View in: PubMed
    Score: 0.003
  25. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics. 2006 May; 117(5):1673-9.
    View in: PubMed
    Score: 0.003
  26. Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Leukemia. 2005 Apr; 19(4):533-6.
    View in: PubMed
    Score: 0.002
  27. Occult ovarian leukemia in childhood acute lymphoblastic leukemia. N Engl J Med. 1982 Apr 22; 306(16):993.
    View in: PubMed
    Score: 0.002
  28. Childhood acute leukemia: a search for occult extramedullary disease prior to discontinuation of chemotherapy. Cancer. 1981 Nov 01; 48(9):1964-6.
    View in: PubMed
    Score: 0.002
  29. A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial. Leukemia. 2001 Jul; 15(7):1038-45.
    View in: PubMed
    Score: 0.002
  30. Childhood leukemia: implications of EEG findings at time of diagnosis. J Pediatr. 1981 Mar; 98(3):437-40.
    View in: PubMed
    Score: 0.002
  31. An outbreak of aspergillosis in children with acute leukemia. J Pediatr. 1979 Jul; 95(1):70-2.
    View in: PubMed
    Score: 0.002
  32. Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol. 1998 Aug; 16(8):2854-63.
    View in: PubMed
    Score: 0.001
  33. Recombinant interferon alfa-2b therapy in children with immune thrombocytopenic purpura. Pediatr Hematol Oncol. 1993 Jul-Sep; 10(3):293-6.
    View in: PubMed
    Score: 0.001
  34. Intensive alternating drug pairs for treatment of high-risk childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study. Cancer. 1993 May 01; 71(9):2854-61.
    View in: PubMed
    Score: 0.001
  35. Therapy-related myelodysplastic syndrome in children with medulloblastoma following MOPP chemotherapy. J Neurooncol. 1992 Sep; 14(1):57-62.
    View in: PubMed
    Score: 0.001
  36. Soft-tissue sarcomas other than rhabdomyosarcoma in children. Med Pediatr Oncol. 1992; 20(2):114-8.
    View in: PubMed
    Score: 0.001
  37. Hemiparesis and ischemic changes of the white matter after intrathecal therapy for children with acute lymphocytic leukemia. Cancer. 1991 Apr 15; 67(8):2058-61.
    View in: PubMed
    Score: 0.001
  38. Typhlitis. An 18-year experience and postmortem review. Cancer. 1990 Feb 15; 65(4):1041-7.
    View in: PubMed
    Score: 0.001
  39. Successful outcome of severe aplastic anemia following Epstein-Barr virus infection. Am J Hematol. 1988 Aug; 28(4):273-5.
    View in: PubMed
    Score: 0.001
  40. Reversible encephalopathy and seizures as a result of conventional vincristine administration. Med Pediatr Oncol. 1988; 16(3):216-9.
    View in: PubMed
    Score: 0.001
  41. Mumps in a general population. A sero-epidemiologic study. Am J Dis Child. 1970 Aug; 120(2):134-8.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.